Home
EYPT
EYPT News

Latest EyePoint Pharmaceuticals Inc. (EYPT) News on July 27, 2024

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

11 days ago

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Milestone Pharmaceuticals Refreshes Board of Directors

GlobeNewswire

12 days ago

Milestone Pharmaceuticals Refreshes Board of Directors

EyePoint Pharmaceuticals to Highlight DURAVYU™ (vorolanib intravitreal insert) Clinical and Regulatory Progress and Pipeline Innovation at R&D Day 2024

GlobeNewswire

a month ago

EyePoint Pharmaceuticals to Highlight DURAVYU™ (vorolanib intravitreal insert) Clinical and Regulatory Progress and Pipeline Innovation at R&D Day 2024

EyePoint Pharmaceuticals to Highlight DURAVYUTM (vorolanib intravitreal insert) Clinical and Regulatory Progress and Pipeline Innovation at R&D Day 2024

GlobeNewswire

a month ago

EyePoint Pharmaceuticals to Highlight DURAVYUTM (vorolanib intravitreal insert) Clinical and Regulatory Progress and Pipeline Innovation at R&D Day 2024

Intra-Cellular (ITCI) Soars 9.6%: Is Further Upside Left in the Stock?

Zacks

a month ago

Intra-Cellular (ITCI) Soars 9.6%: Is Further Upside Left in the Stock?

EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024

GlobeNewswire

a month ago

EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

a month ago

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

2 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

2 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

2 months ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

2 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

2 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

2 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

2 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

2 months ago

Best Date Night Fragrance in 2024

EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire

2 months ago

EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

Insider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)

GuruFocus.com

2 months ago

Insider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)

MT Newswires

2 months ago

JPMorgan Adjusts EyePoint Pharmaceuticals Price Target to $32 From $35, Maintains Overweight Rating

Investing in EyePoint Pharmaceuticals (NASDAQ:EYPT) a year ago would have delivered you a 91% gain

Simply Wall St.

2 months ago

Investing in EyePoint Pharmaceuticals (NASDAQ:EYPT) a year ago would have delivered you a 91% gain

Insider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)

GuruFocus.com

2 months ago

Insider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals Q1 2024 Earnings: Revenue Surpasses Estimates Despite Challenges

GuruFocus.com

3 months ago

EyePoint Pharmaceuticals Q1 2024 Earnings: Revenue Surpasses Estimates Despite Challenges

MT Newswires

3 months ago

Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating

Associated Press Finance

3 months ago

EyePoint Pharmaceuticals: Q1 Earnings Snapshot

EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments

GlobeNewswire

3 months ago

EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments

MT Newswires

3 months ago

Chardan Research Adjusts EyePoint Pharmaceuticals' PT to $28 From $39 After Data From PAVIA Study of Duravyu Disappoint; Keeps Buy Rating

Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?

Benzinga

3 months ago

Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?

MT Newswires

3 months ago

EyePoint Pharmaceuticals Shares Fall After Diabetes Drug Fails to Meet Primary Endpoint

EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy

GlobeNewswire

3 months ago

EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

GlobeNewswire

4 months ago

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Analysts Just Slashed This Year's Revenue Estimates By 22%

Simply Wall St.

5 months ago

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Analysts Just Slashed This Year's Revenue Estimates By 22%

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2023 Earnings Call Transcript

EyePoint Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

5 months ago

EyePoint Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Thomson Reuters StreetEvents

5 months ago

Q4 2023 EyePoint Pharmaceuticals Inc Earnings Call

EyePoint Pharmaceuticals Inc (EYPT) Reports Growth Amidst Strategic Shifts in Q4 and Full-Year 2023

GuruFocus.com

5 months ago

EyePoint Pharmaceuticals Inc (EYPT) Reports Growth Amidst Strategic Shifts in Q4 and Full-Year 2023

Compared to Estimates, EyePoint Pharmaceuticals (EYPT) Q4 Earnings: A Look at Key Metrics

Zacks

5 months ago

Compared to Estimates, EyePoint Pharmaceuticals (EYPT) Q4 Earnings: A Look at Key Metrics

Associated Press Finance

5 months ago

EyePoint Pharmaceuticals: Q4 Earnings Snapshot

EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments

GlobeNewswire

5 months ago

EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments

EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer

GlobeNewswire

5 months ago

EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer

Will EyePoint Pharmaceuticals (EYPT) Report Negative Q4 Earnings? What You Should Know

Zacks

5 months ago

Will EyePoint Pharmaceuticals (EYPT) Report Negative Q4 Earnings? What You Should Know

Here's Why Momentum in EyePoint Pharmaceuticals (EYPT) Should Keep going

Zacks

5 months ago

Here's Why Momentum in EyePoint Pharmaceuticals (EYPT) Should Keep going

EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2024

GlobeNewswire

5 months ago

EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2024

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences

GlobeNewswire

5 months ago

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Are You Looking for a Top Momentum Pick? Why EyePoint Pharmaceuticals (EYPT) is a Great Choice

Zacks

5 months ago

Are You Looking for a Top Momentum Pick? Why EyePoint Pharmaceuticals (EYPT) is a Great Choice

Wall Street Analysts Think EyePoint Pharmaceuticals (EYPT) Could Surge 31.27%: Read This Before Placing a Bet

Zacks

5 months ago

Wall Street Analysts Think EyePoint Pharmaceuticals (EYPT) Could Surge 31.27%: Read This Before Placing a Bet

Here's What Could Help EyePoint Pharmaceuticals (EYPT) Maintain Its Recent Price Strength

Zacks

5 months ago

Here's What Could Help EyePoint Pharmaceuticals (EYPT) Maintain Its Recent Price Strength

EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration

GlobeNewswire

6 months ago

EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration

Buy on the Dip Amid Fed's Tepid Rate Cut Signal: 5 Top Picks

Zacks

6 months ago

Buy on the Dip Amid Fed's Tepid Rate Cut Signal: 5 Top Picks

Michael Austwick Joins Verona Pharma as Non-Executive Director

GlobeNewswire

6 months ago

Michael Austwick Joins Verona Pharma as Non-Executive Director

EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire

6 months ago

EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

EyePoint Pharmaceuticals Inc SVP & Chief Commercial Officer David Jones Sells 26,017 Shares

GuruFocus.com

6 months ago

EyePoint Pharmaceuticals Inc SVP & Chief Commercial Officer David Jones Sells 26,017 Shares

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Federated Hermes Inc Earnings Call

In Bad News for IPO Market, BrightSpring Closes Below Offering Price

The Wall Street Journal

6 months ago

In Bad News for IPO Market, BrightSpring Closes Below Offering Price

Federated Hermes (FHI) Q4 Earnings Top Estimates, Costs Fall

Zacks

6 months ago

Federated Hermes (FHI) Q4 Earnings Top Estimates, Costs Fall

Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares

GuruFocus.com

6 months ago

Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares

EyePoint Pharmaceuticals Inc's Chief Medical Officer Dario Paggiarino Sells 16,386 Shares

GuruFocus.com

6 months ago

EyePoint Pharmaceuticals Inc's Chief Medical Officer Dario Paggiarino Sells 16,386 Shares

Federated Hermes (FHI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

6 months ago

Federated Hermes (FHI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Will Fortinet (FTNT) Beat Estimates Again in Its Next Earnings Report?

Zacks

6 months ago

Will Fortinet (FTNT) Beat Estimates Again in Its Next Earnings Report?

Oil Climbs Above $75 as Winter Shut-Ins Lead to Big Stock Draw

Zacks

6 months ago

Oil Climbs Above $75 as Winter Shut-Ins Lead to Big Stock Draw

Here's Why Fortinet (NASDAQ:FTNT) Has Caught The Eye Of Investors

Simply Wall St.

6 months ago

Here's Why Fortinet (NASDAQ:FTNT) Has Caught The Eye Of Investors

EyePoint Pharmaceuticals Inc SVP & Chief Commercial Officer David Jones Sells 35,066 Shares

GuruFocus.com

6 months ago

EyePoint Pharmaceuticals Inc SVP & Chief Commercial Officer David Jones Sells 35,066 Shares

Marriott Vacations Worldwide Corporation Announces Fourth Quarter Earnings Release and Conference Call

Business Wire

6 months ago

Marriott Vacations Worldwide Corporation Announces Fourth Quarter Earnings Release and Conference Call

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade

Zacks

6 months ago

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade

Fuel to the Fire: 3 Short-Squeeze Candidates

Zacks

6 months ago

Fuel to the Fire: 3 Short-Squeeze Candidates

16 Most Profitable New Stocks Today

Insider Monkey

6 months ago

16 Most Profitable New Stocks Today

Matador Resources Company Announces Date of Fourth Quarter and Full Year 2023 Earnings Release

Business Wire

6 months ago

Matador Resources Company Announces Date of Fourth Quarter and Full Year 2023 Earnings Release

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024

PR Newswire

6 months ago

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024

CoreCivic (NYSE:CXW) May Have Issues Allocating Its Capital

Simply Wall St.

6 months ago

CoreCivic (NYSE:CXW) May Have Issues Allocating Its Capital

Compass Diversified Announces Partnership with The Honey Pot Company

GlobeNewswire

6 months ago

Compass Diversified Announces Partnership with The Honey Pot Company

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT) Intrinsic Value Is Potentially 71% Above Its Share Price

Simply Wall St.

6 months ago

EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT) Intrinsic Value Is Potentially 71% Above Its Share Price

Jim Cramer’s 2024 Predictions and His Top 11 Stock Picks

Insider Monkey

6 months ago

Jim Cramer’s 2024 Predictions and His Top 11 Stock Picks

Why Uranium Energy, Cameco, and Denison Mines Stocks All Popped Today

Motley Fool

6 months ago

Why Uranium Energy, Cameco, and Denison Mines Stocks All Popped Today

New Strong Sell Stocks for January 12th

Zacks

6 months ago

New Strong Sell Stocks for January 12th

EyePoint Pharmaceuticals Inc's Chief Medical Officer Dario Paggiarino Sells 22,913 Shares

GuruFocus.com

6 months ago

EyePoint Pharmaceuticals Inc's Chief Medical Officer Dario Paggiarino Sells 22,913 Shares

Here's Why Envestnet (ENV) is an Attractive Pick Right Now

Zacks

6 months ago

Here's Why Envestnet (ENV) is an Attractive Pick Right Now

Uranium's "Third Bull Market" Set to Shine in 2024

Oilprice.com

6 months ago

Uranium's "Third Bull Market" Set to Shine in 2024

Atkore Inc. Announces First Quarter Fiscal Year 2024 Earnings Release Date and Conference Call

Business Wire

7 months ago

Atkore Inc. Announces First Quarter Fiscal Year 2024 Earnings Release Date and Conference Call

‘Stay Defensive’: Mizuho Says These 2 Energy Stocks Could Weather the Macro Headwinds

TipRanks

7 months ago

‘Stay Defensive’: Mizuho Says These 2 Energy Stocks Could Weather the Macro Headwinds

Patterson-UTI Reports Drilling Activity for December 2023

ACCESSWIRE

7 months ago

Patterson-UTI Reports Drilling Activity for December 2023

The Zacks Analyst Blog Highlights monday.com, Qualys, Gitlab, Fabrinet and Smartsheet

Zacks

7 months ago

The Zacks Analyst Blog Highlights monday.com, Qualys, Gitlab, Fabrinet and Smartsheet

3 Top Tech Stocks Under $20 Per Share

Motley Fool

7 months ago

3 Top Tech Stocks Under $20 Per Share

13 Most Promising Future Stocks To Buy According To Hedge Funds

Insider Monkey

7 months ago

13 Most Promising Future Stocks To Buy According To Hedge Funds

Is There Now An Opportunity In EverCommerce Inc. (NASDAQ:EVCM)?

Simply Wall St.

7 months ago

Is There Now An Opportunity In EverCommerce Inc. (NASDAQ:EVCM)?

Insider Sell Alert: CFO Charles Wickers Sells 19,217 Shares of Rover Group Inc (ROVR)

GuruFocus.com

7 months ago

Insider Sell Alert: CFO Charles Wickers Sells 19,217 Shares of Rover Group Inc (ROVR)

European Automotive Leader Goes Live with Sapiens IDITSuite for Auto Insurance

PR Newswire

7 months ago

European Automotive Leader Goes Live with Sapiens IDITSuite for Auto Insurance

Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone)

Business Wire

8 months ago

Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone)

Credit Acceptance Announces Pricing of $600.0 Million Senior Notes Offering

GlobeNewswire

8 months ago

Credit Acceptance Announces Pricing of $600.0 Million Senior Notes Offering

16 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds

Insider Monkey

8 months ago

16 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds

Shareholders have faith in loss-making Ironwood Pharmaceuticals (NASDAQ:IRWD) as stock climbs 9.7% in past week, taking five-year gain to 2.3%

Simply Wall St.

8 months ago

Shareholders have faith in loss-making Ironwood Pharmaceuticals (NASDAQ:IRWD) as stock climbs 9.7% in past week, taking five-year gain to 2.3%

National Fuel Gas (NFG) Down 4.3% Since Last Earnings Report: Can It Rebound?

Zacks

8 months ago

National Fuel Gas (NFG) Down 4.3% Since Last Earnings Report: Can It Rebound?

Top 25 Natural Gas Producers in the US

Insider Monkey

8 months ago

Top 25 Natural Gas Producers in the US

Sonic Automotive (NYSE:SAH) Has Announced That It Will Be Increasing Its Dividend To $0.30

Simply Wall St.

8 months ago

Sonic Automotive (NYSE:SAH) Has Announced That It Will Be Increasing Its Dividend To $0.30

Sigma Lithium reveals success: profitable quarter, environmental leadership, and low-cost production

News Direct

8 months ago

Sigma Lithium reveals success: profitable quarter, environmental leadership, and low-cost production

Kosmos Energy Ltd. (NYSE:KOS) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Kosmos Energy Ltd. (NYSE:KOS) Q3 2023 Earnings Call Transcript

Apex Systems’ UK Branch Recertified as a Top Workplace by Great Place to Work®

Business Wire

9 months ago

Apex Systems’ UK Branch Recertified as a Top Workplace by Great Place to Work®

Enerplus Announces December Quarterly Dividend

Hart Energy

9 months ago

Enerplus Announces December Quarterly Dividend

Share on Social Networks: